Eli Lilly’s Blockbuster Drug Growth in Q3 2023
N ews (3)
N ews (3)
Analyst Upgrades Boost Outlook
A positive deal with a $125 target from Raymond
Insider Buying Signals Pipeline Confidence
Insider buying of $4 million, including $1 million by the CEO
Novo’s Value Outshines Lilly
Novo Nordisk’s 52-week lows at $67 reflect fears.....
Fund Rotation Signals Overvaluation
The Saudi sovereign fund’s focus on Unit....
Healthcare’s Undervalued Opportunity
Healthcare is the most undervalued sector, with insider buying
Supply Constraints Favor Competitors
Novo’s P/E below its 10-year average and strong
Insider Buying Signals Pipeline Confidence
Insider buying of $4 million, including $1 million by the CEO
Analyst Upgrades Boost Outlook
A positive deal with a $125 target from Raymond
Healthcare’s Undervalued Opportunity
Healthcare is the most undervalued sector, with insider buying
Novo’s Value Outshines Lilly
Novo Nordisk’s 52-week lows at $67 reflect fears.....
Fund Rotation Signals Overvaluation
The Saudi sovereign fund’s focus on Unit....
Supply Constraints Favor Competitors
Novo’s P/E below its 10-year average and strong







